Literature DB >> 26149839

Reply: Warfarin in patients on haemodialysis with atrial fibrillation—friend or foe?

Arman Qamar1, Deepak L Bhatt1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26149839     DOI： 10.1038/nrneph.2015.103

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  11 in total

1.  Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation.

Authors:  Wolfgang C Winkelmayer; Jun Liu; Soko Setoguchi; Niteesh K Choudhry
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-29       Impact factor: 8.237

2.  Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis.

Authors:  Mitesh Shah; Meytal Avgil Tsadok; Cynthia A Jackevicius; Vidal Essebag; Mark J Eisenberg; Elham Rahme; Karin H Humphries; Jack V Tu; Hassan Behlouli; Helen Guo; Louise Pilote
Journal:  Circulation       Date:  2014-01-22       Impact factor: 29.690

3.  Anticoagulation therapy: Balancing the risks of stroke and bleeding in CKD.

Authors:  Arman Qamar; Deepak L Bhatt
Journal:  Nat Rev Nephrol       Date:  2015-02-10       Impact factor: 28.314

4.  Challenging the use of warfarin in patients on dialysis with atrial fibrillation.

Authors:  Georg Schlieper; Jürgen Floege
Journal:  Nat Rev Nephrol       Date:  2015-07-07       Impact factor: 28.314

5.  Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis.

Authors:  Kevin E Chan; Elazer R Edelman; Julia B Wenger; Ravi I Thadhani; Franklin W Maddux
Journal:  Circulation       Date:  2015-01-16       Impact factor: 29.690

6.  Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.

Authors:  Anders Nissen Bonde; Gregory Y H Lip; Anne-Lise Kamper; Peter Riis Hansen; Morten Lamberts; Kristine Hommel; Morten Lock Hansen; Gunnar Hilmar Gislason; Christian Torp-Pedersen; Jonas Bjerring Olesen
Journal:  J Am Coll Cardiol       Date:  2014-12-16       Impact factor: 24.094

7.  Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy.

Authors:  Volker Wizemann; Lin Tong; Sudtida Satayathum; Alex Disney; Takashi Akiba; Rachel B Fissell; Peter G Kerr; Eric W Young; Bruce M Robinson
Journal:  Kidney Int       Date:  2010-01-06       Impact factor: 10.612

8.  Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation.

Authors:  Kevin E Chan; J Michael Lazarus; Ravi Thadhani; Raymond M Hakim
Journal:  J Am Soc Nephrol       Date:  2009-08-27       Impact factor: 10.121

Review 9.  Dilemmas in the management of atrial fibrillation in chronic kidney disease.

Authors:  Holger Reinecke; Eva Brand; Rolf Mesters; Wolf-Rüdiger Schäbitz; Marc Fisher; Hermann Pavenstädt; Günter Breithardt
Journal:  J Am Soc Nephrol       Date:  2008-12-17       Impact factor: 10.121

Review 10.  Atrial fibrillation in CKD: balancing the risks and benefits of anticoagulation.

Authors:  Khai P Ng; Nicola C Edwards; Gregory Y H Lip; Jonathan N Townend; Charles J Ferro
Journal:  Am J Kidney Dis       Date:  2013-06-05       Impact factor: 8.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.